CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 12 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 268,104 | $992,000 | 0.18% |
| Orbimed Advisors | 2,578,174 | $9,539,000 | 0.17% |
| Cormorant Asset Management, LP | 288,168 | $1,066,000 | 0.08% |
| Urban Wealth Management, LLC | 2,762 | $10,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,300 | $153,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 35,024 | $129,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $4,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 12,193 | $45,000 | 0.00% |
| ROYAL BANK OF CANADA | 248 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 7,728 | $29,000 | 0.00% |